III

INHALATION SCIENCES SWEDEN AB

No trades
See on Supercharts

ISAB fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Inhalation Sciences Sweden AB develops and sells patented, labtech equipment for inhalation research. Its products include PreciseInhale, which is an advanced laboratory system that lets scientists measure how inhaled particles act in lungs and affect health; LaminarPace which is a patented tool for drying small amounts of drug substance with very low levels of wastage. The company was founded by Per Magnus Gerde in 2005 and is headquartered in Huddinge, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ISAB does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company